4th TIL Therapies Summit 2022

Contact Name:
TIL Therapies Team
Filed in:
Things to do near Boston, MA » Conferences » Science

Commercialization looks set to propel TIL therapy into the spotlight for adoptive cell therapy, and the 4th TIL Therapies Summit arrives to finally reunite the community in-person this October.

Built to ensure your core functions are up to speed on the cutting-edge advances in TIL therapy, this year focuses on full end-to-end content across pre-clinical research, clinical translation, process development and manufacturing, ensuring you can strengthen your pipelines and achieve your 2022/23 milestones.

Showcasing clinical benefits in multiple indications, discussing novel CRISPR engineering, debating combination approaches and clinical outcomes to enhance TIL function in the hostile tumor microenvironment, this is a conversation not to miss.

With 20+ world-class speakers and over 100 senior attendees from around the globe, join the largest community of TIL-targeted drug development experts for a deep dive into clinical development progress, lessons learnt and novel strategies to maximize TIL-targeting to recognize and capitalize on this outstanding approach in adoptive cell therapy!

Website: https://go.evvnt.com/1173496-0?pid=176 
Brochure: https://go.evvnt.com/1173496-1?pid=176 
Tickets: https://go.evvnt.com/1173496-2?pid=176 

Time: 08:00 - 16:00

Conference Only Drug Developers (Earlybird rates available): USD 2799.00,
Conference Only Academic (Earlybird rates available): USD 2199.00,
Conference Only Service Providers (Earlybird rates available): USD 3399.00,
Conference + Workshop Day Drug Developers (Earlybird rates available): USD 4446.00,
Conference + Workshop Day Academic (Earlybird rates available): USD 3246.00,
Conference + Workshop Day Service Providers (Earlybird rates available): USD 5346.00

Speakers: Andrew Weinberg Chief Scientific Officer AgonOx, Ulrik Cordes Founder and Chief Executive Officer Cbio, Sylvia Lee Associate Professor, Program in Immunology Clinical Research Division Fred Hutchinson Cancer Research Center, Nicholas Restifo Stealth Explorer Immunotherapy, Mark Dudley Chief Scientific Officer InsTIL Bio, Tom Henley Chief Scientific Officer Intima Biosciences, Parameswaran Hari Senior Vice President, Clinical Sciences Iovance Biotherapeutics, Stephen Macrides Senior Vice President, Supply Chain and Logistics Iovance Biotherapeutics, Stephanie Woodall Director - Head of Quality KSQ Therapeutics, Karrie Wong Director Cell Therapy KSQ Therapeutics, Micah Benson Senior Vice President Immunology KSQ Therapeutics, Kumar Karyampudi Director Cell Therapy Facility Moffit Cancer Center, Michael Lotze Chief Cellular Therapy Officer Nurix Therapeutics, Jan Ter Meulen Chief Scientific Officer Obsidian Therapeutics, Moran Meiron Director of Advanced Therapies Orgenesis Inc, Eduardo Davila Professor and Director of Immunotherapy Medical Oncology, University of Colorado Comprehensive Cancer Center, Simon Turcotte Associate Professor of Surgery, T Cell Immunotherapy Program Lead Université de Montréal Centre hospitalier de l'Université de Montréal, Daniel J Powell Jr Associate Professor of Pathology and Laboratory Medicine University of Pennsylvania, Peter Prieto Assistant Professor University of Rochester, Lee Stern Vice President, IR and External Communications Achilles Therapeutics


Street Address

Embassy Suites by Hilton Boston at Logan Airport, 207 Porter Street
Boston, MA 02128


  View Calendar